A governance framework for AI in clinical genomics is a mandatory control system, not an optional best practice. It transforms AI from a research tool into a regulated clinical device by enforcing audit trails for every model decision, establishing a versioned model registry, and defining clear Human-in-the-Loop (HITL) workflows for high-risk predictions. This technical scaffolding is essential for compliance with CLIA/CAP and builds institutional trust in automated diagnostics.
Guide
Setting Up a Governance Framework for AI in Clinical Genomics

This guide establishes the technical and procedural foundation for governing AI models in diagnostic settings, ensuring compliance, transparency, and patient safety.
Implementation requires specific tools and protocols. You will set up a model registry using MLflow to track experiments, lineage, and deployments. For auditability, you must log all inputs, model versions, outputs, and reviewer actions to an immutable database. Crucially, you will engineer approval gates—such as requiring geneticist sign-off for variants of uncertain significance—directly into the inference pipeline, creating a transparent, defensible process for every patient case.
Governance Component Comparison
A technical comparison of core components for an AI governance framework in clinical genomics, detailing implementation choices and their trade-offs.
| Governance Component | Centralized Registry (MLflow) | Decentralized Ledger (Blockchain) | Hybrid Approach (MLflow + Smart Contracts) |
|---|---|---|---|
Audit Trail Integrity | High (immutable logs) | Very High (cryptographically sealed) | Very High (ledger-backed logs) |
Model Version Provenance | |||
Human-in-the-Loop (HITL) Workflow Integration | Native (via MLflow Model Registry) | Custom (requires smart contract development) | Flexible (MLflow UI + contract triggers) |
Real-Time Compliance (CLIA/CAP) Flagging | Requires custom monitoring layer | Native via on-chain rule execution | Hybrid (on-chain rules, MLflow alerts) |
Data Lineage for Training Sets | Manual tracking required | Native (hashed data references on-chain) | Selective (critical data on-chain) |
Performance & Latency for Clinical Review | < 100 ms | 2-5 sec (consensus delay) | < 500 ms |
Integration Complexity with Existing MLOps | Low | High | Medium |
Operational Cost (Annual, Est.) | $10-50K (cloud infra) | $100-500K (node ops + dev) | $50-150K (mixed infra) |
Enabling Efficiency, Speed & Accuracy
Intelligent Analysis, Decision & Execution
We build AI systems for teams that need search across company data, workflow automation across tools, or AI features inside products and internal software.
Talk to Us
Search across company data
Give teams answers from docs, tickets, runbooks, and product data with sources and permissions.
Useful when people spend too long searching or get different answers from different systems.

Automate internal workflows
Use AI to route work, draft outputs, trigger actions, and keep approvals and logs in place.
Useful when repetitive work moves across multiple tools and teams.

Add AI to products and internal tools
Build assistants, guided actions, or decision support into the software your team or customers already use.
Useful when AI needs to be part of the product, not a separate tool.
Common Mistakes
Implementing an AI governance framework in clinical genomics is a complex technical and procedural challenge. Developers and engineering leads often stumble on specific pitfalls that can compromise compliance, model reliability, and patient safety. This section addresses the most frequent and critical mistakes.
A model registry like MLflow is essential for tracking versions, artifacts, and metadata, but it is a passive catalog. Governance requires active, enforceable policies. A common mistake is assuming the registry itself enforces Human-in-the-Loop (HITL) approvals, bias monitoring, or audit trail completeness.
True governance integrates the registry with orchestration systems. You must build automated gates that prevent a model from progressing to a clinical environment without passing validation checks, documented approvals, and successful bias audits. The registry should be the source of truth, but the CI/CD pipeline and MLOps workflows enforce the rules.

About the author
Prasad Kumkar
CEO & MD, Inference Systems
Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.
His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.
Partnered with leading AI, data, and software stack.
How We Work
Custom AI workflows for your Business
One-fit-all AI don't work for modern businesses. At Inferensys, we aim to understand your business & custom requirements; which we use to define most efficient agentic workflows, the data, and the tools for your business.
01
Review the use case
We understand the task, the users, and where AI can actually help.
Read more02
Pick the right approach
We define what needs search, automation, or product integration.
Read more03
Build the first useful version
We implement the part that proves the value first.
Read more04
Improve from there
We add the checks and visibility needed to keep it useful.
Read moreThe first call is a practical review of your use case and the right next step.
Talk to Us